How long does stem cell therapy for Rheumatoid Arthritis last?
Durable disease modification has not been established for a generic cell infusion. A temporary symptom or inflammatory-marker change does not show prevention of joint damage, and repeated injections do not prove cumulative benefit.
How stem cells are studied for Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic inflammatory autoimmune disease that can damage joints and other organs. MSC and other cell products are investigated for immune modulation, but they are distinct from disease-modifying antirheumatic drugs (DMARDs) and do not have established ability to reverse structural joint damage. Autologous origin, local injection or an anti-inflammatory laboratory signal does not prove clinical efficacy.
Am I a candidate? → · Rheumatoid Arthritis: full overview → · Rheumatoid Arthritis cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Rheumatoid Arthritis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Rheumatoid Arthritis cost? (2026)
- Rheumatoid Arthritis stem cell therapy — your questions answered (2026)
- Rheumatoid Arthritis: cell-therapy evidence by therapy class
- MSC vs HSCT for Rheumatoid Arthritis: what the registries show